Advertisement
New Zealand markets closed
  • NZX 50

    11,698.51
    -166.38 (-1.40%)
     
  • NZD/USD

    0.6124
    -0.0020 (-0.32%)
     
  • ALL ORDS

    7,943.60
    -31.20 (-0.39%)
     
  • OIL

    78.40
    -0.05 (-0.06%)
     
  • GOLD

    2,334.70
    -14.40 (-0.61%)
     

Here's How Moderna Plans to Win in the Post-Emergency COVID Vaccine Market

Here's How Moderna Plans to Win in the Post-Emergency COVID Vaccine Market

High demand for coronavirus vaccines earlier in the pandemic pushed Moderna's (NASDAQ: MRNA) earnings into the stratosphere. In fact, Moderna could continue to generate billions in revenues annually from its first -- and so far, only -- approved product. For example, Moderna sold its vaccine to the U.S. government for about $26 a dose.